Sales N, Martres M P, Bouthenet M L, Schwartz J C
Laboratoire de Physiologie, Faculté de Pharmacie, Paris, France.
Neuroscience. 1989;28(3):673-700. doi: 10.1016/0306-4522(89)90014-6.
[125I]Iodosulpride, a highly selective and sensitive probe for dopamine D-2 receptors, was used to study the expression of these receptors in binding studies performed on membranes and serial autoradiographic sections, throughout pre- and postnatal developmental periods. D-2 receptors were first detected autoradiographically in sensory and sympathetic ganglia at the embryonic age of 12 days, i.e. much earlier than in previous studies. In membrane binding studies, D-2 receptors were found to be modulated by guanylnucleotides as early as at embryonic day 15, suggesting that they were already functionally coupled to a regulatory G protein. The overall development of D-2 receptors in the central nervous system occurred according to a caudorostral gradient and was accompanied by a slightly but significantly increased affinity for dopamine, possibly related to the late expression of a D-2 receptor subclass. The ontogeny of D-2 receptors was compared to that of tyrosine hydroxylase immunoreactivity as reported by others and taken as an index of dopaminergic innervation. Despite some variations due to experimental conditions, this comparison resulted in the definition of various situations. In some major projection areas (e.g. caudate putamen at embryonic day 14) there was a simultaneous appearance of both dopaminergic markers whereas in most others (e.g. n. accumbens or olfactory tubercles at embryonic day 20) the appearance of D-2 receptors was preceded by 1-4 days by that of tyrosine hydroxylase immunoreactivity. However, in a few projection areas (e.g. the bed nucleus of the stria terminalis at embryonic day 21), D-2 receptors appeared 3-4 days earlier than tyrosine hydroxylase immunoreactivity. In areas of dopaminergic perikarya, e.g. substantia nigra and ventral tegmental area, where they largely correspond to somatodendritic autoreceptors, D-2 receptors appeared at embryonic days 17 and 21 respectively, i.e. 3-8 days after tyrosine hydroxylase immunoreactivity, suggesting that dopamine synthesis and release is not feedback regulated by autoreceptors at initial developmental stages. In areas where D-2 receptors are present in the absence of any established dopaminergic innervation (e.g. discrete layers of the hippocampus, cerebellum, parietal cortex or in cranial nerve nuclei), they generally appeared at a late stage, i.e. during the second or even the third postnatal week. Finally, there was transient and roughly concomitant expression of both D-2 receptors and tyrosine hydroxylase immunoreactivity in some areas such as spinal ganglia or the lateral ventricle floor, consistent with a possible development function of dopamine mediated by D-2 receptors.
[125I]碘舒必利是一种用于多巴胺D-2受体的高度选择性和灵敏性探针,在整个产前和产后发育阶段,用于在膜和连续放射自显影片上进行的结合研究中,研究这些受体的表达。在胚胎12天龄时,首次在感觉和交感神经节中通过放射自显影检测到D-2受体,即比以前的研究早得多。在膜结合研究中,早在胚胎第15天就发现D-2受体受鸟苷酸调节,这表明它们已经在功能上与调节性G蛋白偶联。中枢神经系统中D-2受体的整体发育是按照尾端到吻端的梯度进行的,并且伴随着对多巴胺的亲和力略有但显著增加,这可能与D-2受体亚类的后期表达有关。将D-2受体的个体发生与其他人报道的酪氨酸羟化酶免疫反应性的个体发生进行比较,并将其作为多巴胺能神经支配的指标。尽管由于实验条件存在一些差异,但这种比较得出了各种情况的定义。在一些主要投射区域(例如胚胎第14天的尾状壳核),两种多巴胺能标记同时出现,而在大多数其他区域(例如胚胎第20天的伏隔核或嗅结节),D-2受体的出现比酪氨酸羟化酶免疫反应性早1-4天。然而,在少数投射区域(例如胚胎第21天的终纹床核),D-2受体比酪氨酸羟化酶免疫反应性早3-4天出现。在多巴胺能神经元胞体区域,例如黑质和腹侧被盖区,它们在很大程度上对应于树突体自身受体,D-2受体分别在胚胎第17天和第21天出现,即酪氨酸羟化酶免疫反应性出现后3-8天,这表明在初始发育阶段,多巴胺的合成和释放不受自身受体的反馈调节。在没有任何已建立的多巴胺能神经支配的情况下存在D-2受体的区域(例如海马、小脑、顶叶皮质的离散层或脑神经核),它们通常在后期出现,即在出生后第二周甚至第三周出现。最后,在一些区域,如脊髓神经节或侧脑室底部,D-2受体和酪氨酸羟化酶免疫反应性有短暂且大致同时的表达,这与D-2受体介导的多巴胺可能的发育功能一致。